on avastin's Comments

Micromet: More Reasons for Optimism

Wed, 13 May 2009 13:37:53 -0400

my mistake. thanks for the clarification.

On May 13 12:47 AM Ohad Hammer wrote:

> I am not aware of a SGEN drug for ALL.
> They have drugs for all the other acronyms, NHL, AML,MM,HL and ALCL
> from what I know ;)
>
> SGEN is developing an anti-CD19 antibody drug conjugate but it is
> still in pre clinical stages, so I don't know which patient population
> they'll target.
>
> ohad

Micromet: More Reasons for Optimism

Wed, 13 May 2009 00:38:49 -0400

is miti's ALL drug in the same patient population as SGEN's ALL drug?

Bright Prospects for Micromet (Part 2)

Sat, 25 Apr 2009 11:31:09 -0400

so can you get a picture of one of these devices?

Genentech's Trastuzumab-Dm1 Shows Great Promise in Treating Breast Cancer

Sun, 25 Jan 2009 16:02:56 -0500

"Overall, patients given Avastin in combination with IFL survived about five months longer and the average time before tumors started regrowing or new tumors appeared was four months longer than patients receiving IFL alone."

www.fda.gov/bbs/topics...

don't know where you got 2 months in colorectal. i think you maybe thinking of lung cancer:
"The median overall survival time for patients in the Avastin plus carboplatin and paclitaxel arm was 12.3 months versus 10.3 months for patients receiving only carboplatin and paclitaxel. "

www.fda.gov/bbs/topics...

and on cost, i think you're using the cost for lung cancer (and maybe breast too) but i think the cost for colorectal is 40k/yr.

On Jan 07 01:04 AM carey_jim wrote:

> I have to disagree with the previous comment. Your article was not
> clear to me.
>
> After plodding through the statistics (and admittedly giving up in
> frustration) from what I gather, your article confirms what is already
> clear and it is that the American pharmaceutical industry is completely
> bankrupt and even immoral in its search for a cure for cancer.

>
> Avastin, the other 'blockbuster' drug from Genentech, costs about
> $100,000 only to prolong the lives of advanced colon cancer patients
> by about two months.
>
> Cancer cure rates have remained almost flat for over twenty years.
>
>
> The profit motive doesn't seem to work well in science.
>
> Einstein wasn't interested in physics for the money.
>
> If Einstein had profited from his discoveries, he and his descendants
> would have become the richest people in the world (and possibly controlled
> the entire world.)
>
> My guess is that the drug discovery model will change in the near
> future and that pharmaceutical companies will fall on, at least compared
> with the past, hard times.
>
> Just a hunch, of course.

Genentech Q3 2008 Earnings Call Transcript

Fri, 17 Oct 2008 12:22:18 -0400

"We also believe it will allow us to defend this space from future competitors, including [panitumamab]."
should read:
"We also believe it will allow us to defend this space from future competitors, including ofatumumab."

What Price Might Roche Pay for DNA?

Mon, 04 Aug 2008 02:42:46 -0400

if roche can pay "any price" why offer 89$/sh? y not less, say 9$/sh?